X-152189820-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2
The NM_000808.4(GABRA3):āc.1053T>Cā(p.Ser351=) variant causes a synonymous change. The variant allele was found at a frequency of 0.0000315 in 1,207,837 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.000045 ( 0 hom., 0 hem., cov: 23)
Exomes š: 0.000030 ( 0 hom. 7 hem. )
Consequence
GABRA3
NM_000808.4 synonymous
NM_000808.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.92
Genes affected
GABRA3 (HGNC:4077): (gamma-aminobutyric acid type A receptor subunit alpha3) GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant X-152189820-A-G is Benign according to our data. Variant chrX-152189820-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 759361.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAdExome4 at 7 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRA3 | NM_000808.4 | c.1053T>C | p.Ser351= | synonymous_variant | 9/10 | ENST00000370314.9 | NP_000799.1 | |
GABRA3 | XM_006724811.4 | c.931+7813T>C | intron_variant | XP_006724874.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRA3 | ENST00000370314.9 | c.1053T>C | p.Ser351= | synonymous_variant | 9/10 | 1 | NM_000808.4 | ENSP00000359337 | P1 | |
GABRA3 | ENST00000535043.1 | c.1053T>C | p.Ser351= | synonymous_variant | 9/10 | 1 | ENSP00000443527 | P1 | ||
GABRA3 | ENST00000497894.1 | n.124T>C | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000450 AC: 5AN: 111184Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33352
GnomAD3 genomes
AF:
AC:
5
AN:
111184
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33352
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000822 AC: 15AN: 182578Hom.: 0 AF XY: 0.0000596 AC XY: 4AN XY: 67096
GnomAD3 exomes
AF:
AC:
15
AN:
182578
Hom.:
AF XY:
AC XY:
4
AN XY:
67096
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000301 AC: 33AN: 1096653Hom.: 0 Cov.: 29 AF XY: 0.0000193 AC XY: 7AN XY: 362053
GnomAD4 exome
AF:
AC:
33
AN:
1096653
Hom.:
Cov.:
29
AF XY:
AC XY:
7
AN XY:
362053
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000450 AC: 5AN: 111184Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33352
GnomAD4 genome
AF:
AC:
5
AN:
111184
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33352
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2023 | GABRA3: BP4, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 16, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at